Baltimore Oral Epidemiology, Disease Effects, and HIV Evaluation Study (BEEHIVE)
巴尔的摩口腔流行病学、疾病影响和 HIV 评估研究 (BEEHIVE)
基本信息
- 批准号:10668433
- 负责人:
- 金额:$ 91.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcquired Immunodeficiency SyndromeAddressAffectAfrican American populationAgeAgingBaltimoreBiologicalCardiovascular systemCaringCessation of lifeChronicChronic DiseaseClinicalCommunitiesDental CareDental EpidemiologyDentistsDiabetes MellitusDiagnosticDimensionsDiseaseDisease ManagementDisease MarkerDisease ProgressionDisparityEpidemiologistEpidemiologyEvaluation StudiesFundingFutureHIVHIV InfectionsHIV SeronegativityHIV therapyHealth StatusHealthcareHeart DiseasesHigh PrevalenceImmunosuppressionIndividualInflammatoryInterventionInterviewIntravenousInvestigationJointsKidneyLife ExpectancyLife StyleLinkLiverLow incomeLungMedical RecordsMetabolicMethodsMorbidity - disease rateMouth DiseasesMucous MembraneNeurocognitiveOralOral healthOrganPatient Self-ReportPatternPeriodontal DiseasesPeriodontitisPeriodontiumPersonsPharmaceutical PreparationsPhenotypePhylogenetic AnalysisPhysiciansPopulationPopulations at RiskPrevalencePrincipal Component AnalysisRecording of previous eventsRegistriesResearchResearch PersonnelRisk BehaviorsRisk FactorsSalivarySeveritiesSystemTherapeutic InterventionTimeUnited StatesUnited States National Institutes of HealthViralViremiaVisitage relatedagedantiretroviral therapybonecare seekingclinical examinationcohortcomorbiditydisabilityexperiencehealth care servicehealth literacyinsightlifestyle factorslongitudinal analysismetabolomicsmetaproteomicsmetatranscriptomicsmicrobiomemicrobiome compositionmicrobiome signaturemodifiable riskmortalitymultidisciplinarynoveloral microbiomeprognosticretention ratesocialsystemic inflammatory response
项目摘要
Since the advent of antiretroviral therapy (ART), the life expectancy of persons living with HIV (PLWH) has
steadily increased in the United States. PLWH are now more likely to develop co-morbid age-related non-
communicable diseases (NCDs) than are similarly-aged HIV-uninfected persons, and the morbidity and
mortality of NCD and age-related conditions is paramount. The age-adjusted rates of multiple NCDs are higher
among PLWH than among persons who are HIV negative. In addition, PLWH experience higher prevalence
and severity of oral diseases, particularly related to the periodontium, although the factors that explain these
disparities remain unclear. For example, is HIV-related immune suppression or viremia primarily responsible
for these differences? Are lifestyle factors and access to dental care important determinants? Is the
microbiome signature in PLWH unique and does it change over time? Since 1988, the AIDS Linked to the
Intravenous Experience (ALIVE) study has successfully followed a lower-income, predominantly African
American population of HIV-infected and at-risk persons with a history of injecting drugs (PWID) in a
community-based cohort in Baltimore. Over three decades, ALIVE has characterized risk factors of incident
HIV and progression to AIDS or death, described patterns of risk behaviors, identified barriers to optimal HIV
care, and provided important insights into the natural and treated course of HIV among PWID. In recent years,
ALIVE has transitioned to exploring the impact of aging with HIV, focusing on phenotypes and organ-specific
non-communicable diseases (NCD) (e.g., liver, lung, cardiovascular, bone, kidney, neurocognitive and
metabolic NCDs). The proposed project leverages the ALIVE platform to focus on the combined effects of HIV
and NCDs on oral health at the health care-seeking, clinical, and microbiological levels. The specific aims of
the proposed project are to: 1) determine to what extent HIV status influences access to and utilization of oral
health care services; 2) determine to what extent HIV status affects self-reported and clinical oral health status;
3) determine to what extent HIV status influences the progression of periodontitis; and 4) determine to what
extent HIV status impacts the periodontitis-associated oral microbiome signature. The first three specific aims
include sub-aims that define the extent to which comorbid NCDs act as effect modifiers. For specific aim 4, one
sub-aim describes the extent to which HIV influences the oral microbiome and a second sub-aim defines how
longitudinal changes in the oral microbiome signature affect periodontitis progression. To achieve these aims,
we build upon biannual ALIVE study visits with interview, clinical examination, and biospecimen components,
supplemented by medical record review and registry linkages. The key impact of these aims is to illuminate
social and individual-level mechanisms, identify modifiable risk factors, and produce novel insights to inform
efficient and targeted oral health interventions for PLWH in Baltimore and nationally.
自从抗逆转录病毒疗法(ART)问世以来,艾滋病毒携带者(PLWH)的预期寿命
在美国稳步增长。PLWH现在更有可能发展为与年龄无关的共病
传染性疾病(NCDs)比同龄艾滋病毒非感染者更多,发病率和
非传染性疾病和年龄相关疾病的死亡率是最重要的。多重非传染性疾病的年龄调整率较高
与艾滋病毒阴性者相比,PLWH患者中的这一比例更高。此外,PLWH的患病率更高
口腔疾病的严重程度,特别是与牙周组织有关的疾病,尽管解释这些的因素
差距仍然不明朗。例如,艾滋病毒相关免疫抑制或病毒血症是主要原因吗?
这些不同之处?生活方式因素和获得牙科保健是重要的决定因素吗?是
PLWH中的微生物组特征是独一无二的,它会随着时间的推移而变化吗?自1988年以来,艾滋病与
静脉注射体验(ALIVE)研究成功地跟踪了一名低收入人群,主要是非洲人
美国有注射吸毒史的艾滋病毒感染者和高危人群(PWID)
巴尔的摩以社区为基础的队列。三十多年来,Alive一直是事故风险因素的特征
艾滋病毒与艾滋病或死亡的进展,描述了危险行为的模式,确定了最佳艾滋病毒的障碍
并提供了对残疾人中艾滋病毒的自然和治疗过程的重要见解。近年来,
Alive已经过渡到探索衰老对艾滋病毒的影响,重点是表型和器官特异性
非传染性疾病(例如,肝、肺、心血管、骨、肾、神经认知和
代谢性非传染性疾病)。拟议的项目利用Alive平台,重点关注艾滋病毒的综合影响
以及非传染性疾病在求医、临床和微生物层面对口腔健康的影响。的具体目标
拟议项目是:1)确定艾滋病毒状况在多大程度上影响获得和利用口腔
卫生保健服务;2)确定艾滋病毒状况对自我报告和临床口腔健康状况的影响程度;
3)确定艾滋病毒状况在多大程度上影响牙周炎的进展;以及4)确定对什么影响
艾滋病毒状况对牙周炎相关口腔微生物组签名的影响程度。前三个具体目标
包括确定共患非传染性疾病在多大程度上充当效果修饰剂的子目标。具体目标4,一
子目标描述了艾滋病毒对口腔微生物群的影响程度,第二个子目标定义了
口腔微生物组特征的纵向变化影响牙周炎的进展。为了实现这些目标,
我们在一年两次的活体研究访问的基础上,通过访谈、临床检查和生物显微镜组件,
并辅之以病历审查和登记联系。这些目标的关键影响是阐明
社会和个人层面的机制,确定可更改的风险因素,并产生新的见解以提供信息
在巴尔的摩和全国对PLWH进行有效和有针对性的口腔健康干预。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory D Kirk其他文献
Risk of anal cancer in HIV-infected patients and HIV-uninfected controls in North America
- DOI:
10.1186/1750-9378-5-s1-a70 - 发表时间:
2010-10-11 - 期刊:
- 影响因子:2.800
- 作者:
Michael J Silverberg;Bryan Lau;Yuezhou Jing;Gypsyamber D'Souza;Eric A Engels;John Gill;James J Goedert;Gregory D Kirk;Amy Justice;Robert Dubrow - 通讯作者:
Robert Dubrow
Association of Primary Care Engagement with Initiation and Continuation of Medication Treatment for Opioid Use Disorder Among Persons with a History of Injection Drug Use
初级保健参与与有注射吸毒史的人开始和继续阿片类药物使用障碍药物治疗的关系
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:4.2
- 作者:
D. Sosnowski;K. Feder;Becky L. Genberg;S. Mehta;Gregory D Kirk - 通讯作者:
Gregory D Kirk
Association of immunosuppression and HIV viremia with anal cancer risk in persons living with HIV in the United States and Canada.
美国和加拿大艾滋病毒感染者的免疫抑制和艾滋病毒病毒血症与肛门癌风险的关联。
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:11.8
- 作者:
R. Hernández;L. Qin;Haiqun Lin;W. Leyden;Romain S. Neugebauer;K. Althoff;N. Hessol;Chad J. Achenbach;J. T. Brooks;M. Gill;S. Grover;M. Horberg;Jun Li;W. C. Mathews;Á. Mayor;P. Patel;Charles S Rabkin;A. Rachlis;Amy C. Justice;Richard D. Moore;Eric A. Engels;M. Silverberg;R. Dubrow;Constance A. Benson;Ronald J. Bosch;Gregory D Kirk;Kenneth H. Mayer;C. Grasso;Robert S. Hogg;P. Richard Harrigan;J. Montaner;B. Yip;Julia Zhu;K. Salters;Karyn Gabler;K. Buchacz;Jun Li;K. Gebo;Richard D. Moore;B. Rodriguez;M. Horberg;M. Silverberg;Jennifer E. Thorne;Charles S Rabkin;Joseph B. Margolick;Lisa P. Jacobson;Gypsyamber D'Souza;M. Klein;A. Kroch;Ann N. Burchell;Adrian Betts;Joanne D. Lindsay;R. Hunter;Á. Mayor;M. John Gill;S. Deeks;Jeffrey N. Martin;J. T. Brooks;M. Saag;M. Mugavero;James Willig;W. C. Mathews;Joseph J Eron;S. Napravnik;M. Kitahata;Heidi M Crane;D. Drozd;Timothy R. Sterling;David Haas;Peter F. Rebeiro;M. Turner;Amy C. Justice;R. Dubrow;David A. Fiellin;S. Gange;K. Anastos;K. Althoff;R. Mckaig;Aimee M. Freeman;Stephen E. Van Rompaey;Liz Morton;J. McReynolds;William Lober;Jennifer S. Lee;Bin You;B. Hogan;Jinbing Zhang;Jerry Jing;E. Humes;Sally B Coburn - 通讯作者:
Sally B Coburn
Gregory D Kirk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory D Kirk', 18)}}的其他基金
Research Supplements to Promote Diversity in Health-Related Research
促进健康相关研究多样性的研究补充
- 批准号:
10643214 - 财政年份:2020
- 资助金额:
$ 91.04万 - 项目类别:
Antiviral treatment as prevention for HBV- and HBV/HIV-associated hepatocellular carcinoma
抗病毒治疗预防 HBV 和 HBV/HIV 相关肝细胞癌
- 批准号:
10689163 - 财政年份:2020
- 资助金额:
$ 91.04万 - 项目类别:
Antiviral treatment as prevention for HBV- and HBV/HIV-associated hepatocellular carcinoma
抗病毒治疗预防 HBV 和 HBV/HIV 相关肝细胞癌
- 批准号:
10259886 - 财政年份:2020
- 资助金额:
$ 91.04万 - 项目类别:
Baltimore Oral Epidemiology, Disease Effects, and HIV Evaluation Study (BEEHIVE)
巴尔的摩口腔流行病学、疾病影响和 HIV 评估研究 (BEEHIVE)
- 批准号:
10223266 - 财政年份:2020
- 资助金额:
$ 91.04万 - 项目类别:
Study of HIV Infection in the Etiology of Lung Disease (SHIELD) AIR: Air Pollution Impact on Respiratory Health in HIV
HIV 感染与肺部疾病病因学研究 (SHIELD) 空气:空气污染对 HIV 呼吸系统健康的影响
- 批准号:
10664953 - 财政年份:2020
- 资助金额:
$ 91.04万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 91.04万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 91.04万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 91.04万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 91.04万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 91.04万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 91.04万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 91.04万 - 项目类别:














{{item.name}}会员




